References
- United Nations Against AIDS (UNAIDS) data 2018. Available from: http://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf. Assessed April 11, 2019.
- Antiretroviral Therapy Cohort Collaboration. Survival of HIV-positive patients starting antiretroviral therapy between 1996 and 2013: a collaborative analysis of cohort studies. Lancet HIV. 2017;4(8):e349–e356. doi:10.1016/S2352-3018(17)30066-8.28501495
- Machtinger EL, Bangsberg DR. Seven steps to better adherence: a practical approach to promoting adherence to antiretroviral therapy. AIDS Read. 2007;17(1):43–51. Available from: https://www.ncbi.nlm.nih.gov/pubmed?cmd=historysearch&querykey=1.17274147
- The Fifth South African National HIV Prevalence Incidence behaviour and communication survey_ 2017.pdf. Available from: https://serve.mg.co.za/content/documents/2018/07/17/7M1RBtUShKFJbN3NL1Wr_HSRC_HIV_Survey_Summary_2018.pdf. Accessed April 11, 2019.
- World Health Organization, Geneva, 2015 Guideline on when to start antiretroviral therapy and on pre-exposure prophylaxis for HIV. Available from: http://www.ncbi.nlm.nih.gov/books/NBK327115/. Accessed 6 2018.
- National Department of Health, Pretoria, South Africa 2016 National policy on hiv pre-exposure prophylaxis (PrEP) and test and treat (T&T). Accessed 26, 2019 Available from: https://sahivsoc.org/Files/PREP%20and%20TT%20Policy%20-%20Final%20Draft%20-%205%20May%202016%20(HIV%20news).pdf
- Bor J, Ahmed S, Fox MP, et al. Effect of eliminating CD4-count thresholds on HIV treatment initiation in South Africa: an empirical modeling study. PLoS One. 2017;12(6):e0178249. doi:10.1371/journal.pone.017824928617805
- Stevens WS, Marshall TM. Challenges in implementing HIV load testing in South Africa. J Infect Dis. 2010;201(Suppl1):S78–S84. doi:10.1086/65038320225952
- McMahon JH, Elliott JH, Bertagnolio S, Kubiak R, Jordan MR. Viral suppression after 12 months of antiretroviral therapy in low- and middle-income countries: a systematic review. Bull World Health Organ. 2013;91(5):377–385E. Available from: http://www.who.int/entity/bulletin/volumes/91/5/12-112946.pdf.23678201
- Cosby CD. Hematologic disorders associated with human immunodeficiency virus and AIDS. J Infusion Nurs. 2007;30(1):22–32. doi:10.1097/00129804-200701000-00005
- Denue BA, Yusuf I, Bello HS, Abja AU, Bukar A. Changes in blood profile of human immunodeficiency virus (HIV)-infected patients on highly active antiretroviral therapy (HAART) in North Eastern Nigeria. Journal AIDS HIV Res. 2013;5(8):284–291.
- Schreibman T, Friedland G. Use of total lymphocyte count for monitoring response to antiretroviral therapy. Clin Infect Dis. 2004;38(2):257–262. doi:10.1086/cid.2004.38.issue-214699459
- Evans D, Maskew M, Fox M, et al. CD4 criteria improves the sensitivity of a clinical algorithm developed to identify viral failure in HIV-positive patients on first-line antiretroviral therapy. J Int AIDS Soc. 2014;17(1):122–123. doi:10.7448/IAS.17.1.19139
- Meriki HD, Tufon KA, Afegenwi MH, et al. Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon. Infect Dis Poverty. 2014;3(1):1–11. doi:10.1186/2049-9957-3-524401663
- Romanelli F, Empey K, Pomeroy C. Macrocytosis as an indicator of medication (zidovudine) adherence in patients with HIV infection. AIDS Patient Care STDS. 2002;16(9):405–411. doi:10.1089/10872910276033024512396692
- Chalker JC, Andualem T, Gitau LN, et al. Measuring adherence to antiretroviral treatment in resource-poor settings: the feasibility of collecting routine data for key indicators. BMC Health Serv Res. 2010;19(10):43. doi:10.1186/1472-6963-10-43
- Zetterberg E, Neuhaus J, Baker VJ, et al. Group the ISS. Platelet count kinetics following interruption of antiretroviral treatment. AIDS. 2013;29(6):997–1003.
- Nnambalirwa M, Govathson C, Evans D, McNamara L, Maskew M, Nyasulu P. Markers of poor adherence among adults with HIV attending Themba Lethu HIV Clinic, Helen Joseph Hospital, Johannesburg, South Africa. Trans R Soc Trop Med Hyg. 2016;10(12):696–704. Available from: https://academic.oup.com/trstmh/article/110/12/696/3063272.
- Evans D, Fox M. When and how should we be measuring adherence to antiretroviral therapy in resource-limited settings? J Clin Res HIV AIDS Prev. 2013;1(2):24–30. Available from: http://openaccesspub.org/jcrhap/article/43.
- WHO, UNAIDS, UNICEF. Global Report: UNAIDS Report on the Global AIDS Epidemic 2013. Geneva; UNAIDS; 2013:3–5. Accessed 123 2018 Available from: http://fles.unaids.org/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013_en.pdf.
- Fox MP, Van Cutsem G, Giddy J, et al. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. J Acquir Immune Defc Syndr (1999). 2012;60(4):428. doi:10.1097/QAI.0b013e3182557785
- Fox MP, Maskew M, Patrick MacPhail A, et al. Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa. Int J Epidemiol. 2013;42(2):430–439. doi:10.1093/ije/dys16722434860
- Fox MP, Maskew M, Brennan AT, et al. Cohort profile: the Right to Care Clinical HIV Cohort, South Africa. BMJ Open. 2017;7(6):bmjopen-2016–015620 Available from: http://bmjopen.bmj.com/lookup/doi/10.1136/bmjopen-2016-015620
- National Department of Health, Pretoria, South Africa. The South African Antiretroviral Treatment Guidelines 2013. Available from: http://www.kznhealth.gov.za/medicine/2013_art_guidelines.pdf. Accessed April 11, 2019.
- Hirasen K, Evans D, Maskew M, et al. The right combination - Treatment outcomes among HIV-positive patients initiating first-line fixed-dose antiretroviral therapy in a public sector HIV clinic in Johannesburg, South Africa. Clin Epidemiol. 2017;10:17–29. Available from: https://www.dovepress.com/the-right-combination-treatment-outcomes-among-hiv-positive-patients-i-peer-reviewed-article-CLEP.29296098
- Lynen L, An S, Koole O, et al. An algorithm to optimize viral load testing in HIV-positive patients with suspected first-line antiretroviral therapy failure in Cambodia. J Acquir Immune Defic Syndr. 2009;52(1):40–48. doi:10.1097/QAI.0b013e3181af670519550349
- Van Griensven J, Phan V, Thai S, Koole O, Lynen L. Simplified clinical prediction scores to target viral load testing in adults with suspected first line treatment failure in Phnom Penh, Cambodia. PLoS One. 2014;9(2):878–879. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3913697&tool=pmcentrez&rendertype=abstract.
- Robbins GK, Johnson KL, Chang Y, et al. Predicting Virologic Failure in an HIV Clinic. Clin Infect Dis. 2010;50;779–786. Available from: https://academic.oup.com/cid/article-lookup/doi/10.1086/650537.20121574
- Messou E, Gabillard D, Moh R, et al. Anthropometric and immunological success of antiretroviral therapy and prediction of virological success in west African adults. Bull World Health Organ. 2008;86(6):435–442.18568272
- Steel G, Joshi MP, Paige S Antiretroviral therapy adherence measurement and support in South Africa: initial activities from July 4 to 26, 2005. Document Number: 303431 Popline by K4Health 2005 Available from: https://www.popline.org/node/263614. Accessed 26, 2019.
- Amico KR, Fisher WA, Cornman DH, et al. Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. J Acquir Immune Defic Syndr. 2006;42(4):455–459. doi:10.1097/01.qai.0000225020.73760.c216810111
- Berg KM, Arnsten JH. Practical and conceptual challenges in measuring antiretroviral adherence. J Acquir Immune Defic Syndr. 2006;43(SUPPL. 1):1–16. doi:10.1097/01.qai.0000248337.97814.6616936557
- Knobel H, Alonso J, Casado JL, et al. Validation of a simplified medication adherence questionnaire in a large cohort of HIV-infected patients: the GEEMA Study. Aids. 2002;16(4):605–613. doi:10.1097/00002030-200203080-0001211873004
- Famoye F, Rothe DE. Variable selection for poisson regression model. J Mod Appl Stat Methods. 2003; 2(2):380–388. Available from: http://digitalcommons.wayne.edu/jmasm/vol2/iss2/11.
- Hardin JW, Hilbe J. Generalized Linear Models and Extensions. Third press S, editor. Texas: Stata press; 2012:455.
- Seymour DG, Green M, Vaz FG. Making better decisions: construction of clinical scoring systems by the Spiegelhalter-Knill-Jones approach. BMJ. 1990;300(6719):223–226. doi:10.1136/bmj.300.6719.2232106929
- Stata Corps. STATA 13 Software. Stata Statistical Software. College Station, TX: StataCorpLP; 2013.
- Badri M, Cleary S, Maartens G, et al. When to initiate highly active antiretroviral therapy in sub-Saharan Africa? A South African cost-effectiveness study. Antivir Ther. 2006;11(1):63–72.16518961
- Segeral O, Madec Y, Ban B, et al. Simplified assessment of antiretroviral adherence and prediction of virological efficacy in HIV-infected patients in Cambodia. AIDS Res Treat. 2010;2010:142076. doi:10.1155/2010/14207621490902
- Colebunders R, Moses KR, Laurence J, et al. A new model to monitor the virological efficacy of antiretroviral treatment in resource poor countries. Lancet Infect Dis. 2006;6(1):53–59. Available from. doi:10.1016/S1473-3099(05)70327-316377535
- Abouyannis M, Menten J, Kiragga A, et al. Development and validation of systems for rational use of viral load testing in adults receiving first-line ART in sub-Saharan Africa. AIDS. 2011;25(13):1627–1635. Available from: http://content.wkhealth.com/linkback/openurl?sid=WKPTLP:landingpage&an=00002030-201108240-00008.
- Narainsamy D, Mahomed S. Delays in switching patients onto second-line antiretroviral treatment at a public hospital in eThekwini, KwaZulu-Natal. South Afr J HIV Med. 2017;18(1):696 Available from:: http://www.sajhivmed.org.za/index.php/hivmed/article/view/696.29568632
- Chimukangara B, Kharsany ABM, Lessells RJ, et al. Moderate-to-high levels of pretreatment HIV drug resistance in KwaZulu-Natal Province, South Africa. AIDS Res Hum Retroviruses. 2019;35(2):129–138. doi:10.1089/AID.2018.020230430843